par1 antagonist f 16618 (Pierre Fabre Group)
90
Structured Review
Pierre Fabre Group
par1 antagonist f 16618
Par1 Antagonist F 16618, supplied by Pierre Fabre Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/par1+antagonist+f+16618/par1+antagonist+f+16618/pm20188709-14-7-34
Average 90 stars, based on 1 article reviews
Par1 Antagonist F 16618, supplied by Pierre Fabre Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/par1+antagonist+f+16618/par1+antagonist+f+16618/pm20188709-14-7-34
Average 90 stars, based on 1 article reviews
par1 antagonist f 16618 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Effects of a new PAR1 antagonist, F 16618, on smooth muscle cell contraction. Article Snippet: Contents lists available at ScienceDirect European Journal of Pharmacology j ourna l homepage: www.e lsev ie r.com/ locate /e jphar Cardiovascular Pharmacology Effects of a new PAR1 antagonist, F 16618, on smooth muscle cell contraction Arnaud Bocquet, Robert Létienne, Sylvie Sablayrolles, Luc De Vries, Michel Perez, Bruno Le Grand ⁎ Centre de Recherche Pierre Fabre, 17, Avenue Jean Moulin, 81106 Castres Cedex, France ⁎ Corresponding author.. Tel.. : +33 5 63 71 42 51; fax: E-mail address: bruno.le.grand@pierre-fabre.com (B 0014-2999/$ – see front matter © 2009 Elsevier B.V. A doi:10.1016/j.ejphar.2009.03.056 a b s t r a c t a r t i c l e i n f o Article history: Received 9 February 2009 Received in revised form 10 March 2009 Accepted 23 March 2009 Available online 1 April 2009 Keywords: PAR1 antagonist Vessel Vasoconstriction This study evaluated the effects of two PAR1 antagonists on vessels contracted by SFLLR. Activity Assay:Article Title: Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat. Article Snippet: The purpose of the present work was the evaluation of the antithrombotic activity of a new PAR1 antagonist, F 16618 in arterio-venous shunt in the rat.. Arterial thrombosis was induced by insertion of a silk thread (thrombogenic substrate) into an extracorporeal shunt.. F 16618 was administered either by intravenous route (0.63–2.5 mg/kg) or by oral route (20–80 mg/kg). In Vitro:Article Title: Posters Tuesday 15 July Autonomic pharmacology Article Snippet: P053 Non-genomic effects of testosterone on contraction in the mouse vas deferens J Kennard, J Young, K Brain Department of Pharmacology, University of Oxford, Oxford, UK Several studies have demonstrated non-genomic effects of androgens on a range of tissue preparations, characterised by a short time lag and insensitivity to transcription and translation inhibitors (Falkenstein et al., 2000).. It is not known whether there are non-genomic effects of testosterone in the mouse vas deferens, an important model for studying junctional transmission.. Vasa deferentia were excised from eightto twelve-week-old male Balb/C mice (20–40 g) which had been humanely killed by an approved Schedule I method. |